These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 17924986)

  • 61. Short daily hemodialysis and nocturnal hemodialysis at home: practical considerations.
    Lockridge RS; Moran J
    Semin Dial; 2008; 21(1):49-53. PubMed ID: 18251958
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Removal of uremic toxins and regeneration of hemofiltrate by a selective dual hemofiltration artificial kidney (SEDUFARK) system.
    Jørstad S; Smeby LC; Widerøe TE; Berg KJ
    Clin Nephrol; 1980 Feb; 13(2):85-92. PubMed ID: 6988123
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Removal of Cell-Activating Substances Using Dialyzers With Various Permeability Profiles.
    Latosinska A; Hulko M; Speidel R; Mischak H; Storr M; Krause B
    Artif Organs; 2018 Jan; 42(1):78-87. PubMed ID: 28744941
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Blood levels of middle molecules and their effects on motor nerve conduction velocity.
    Botella J; Gea T; Sanz-Guajardo D; Criado M; Torres MT; Guardiola J
    Artif Organs; 1981; 4 Suppl():151-5. PubMed ID: 7295082
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impact of hemodialysis duration on the removal of uremic retention solutes.
    Eloot S; Van Biesen W; Dhondt A; Van de Wynkele H; Glorieux G; Verdonck P; Vanholder R
    Kidney Int; 2008 Mar; 73(6):765-70. PubMed ID: 18160958
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Initial Brazilian experience with short-duration in-center daily hemodialysis.
    Lugon JR; Andre MB
    Hemodial Int; 2005 Jan; 9(1):3-6. PubMed ID: 16191048
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Computational dose predictions for combined treatment of hemofiltration with weekly hemodialysis.
    Lee JC; Park CY; Choi SW; Park JY; Kim JC; Yun YM; Lee KK; Sun K; Min BG
    Comput Methods Programs Biomed; 2008 Mar; 89(3):275-81. PubMed ID: 18155799
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ionic dialysance: principle and review of its clinical relevance for quantification of hemodialysis efficiency.
    Mercadal L; Ridel C; Petitclerc T
    Hemodial Int; 2005 Apr; 9(2):111-9. PubMed ID: 16191058
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of severe metastatic calcification in hemodialysis patients.
    Yeh SM; Hwang SJ; Chen HC
    Hemodial Int; 2009 Apr; 13(2):163-7. PubMed ID: 19432688
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cool dialysate reduces asymptomatic intradialytic hypotension and increases baroreflex variability.
    Chesterton LJ; Selby NM; Burton JO; McIntyre CW
    Hemodial Int; 2009 Apr; 13(2):189-96. PubMed ID: 19432693
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Protein-leaking membranes for hemodialysis: a new class of membranes in search of an application?
    Ward RA
    J Am Soc Nephrol; 2005 Aug; 16(8):2421-30. PubMed ID: 15975998
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adsorption dialysis: from physical principles to clinical applications.
    Aucella F; Gesuete A; Vigilante M; Prencipe M
    Blood Purif; 2013; 35 Suppl 2():42-7. PubMed ID: 23676835
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Automated monitoring of hemodialysis adequacy by dialysis machines: potential benefits to patients and cost savings.
    Daugirdas JT; Tattersall JE
    Kidney Int; 2010 Nov; 78(9):833-5. PubMed ID: 20948540
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 14th International Conference on Dialysis, Advances in Chronic Kidney Disease 2012. Preface.
    Kotanko P; Levin NW; Ronco C
    Blood Purif; 2012; 33(1-3):105-6. PubMed ID: 22269902
    [No Abstract]   [Full Text] [Related]  

  • 75. Advances and innovations in dialysis in the 21st century.
    Power A; Duncan N; Goodlad C
    Postgrad Med J; 2009 Feb; 85(1000):102-7. PubMed ID: 19329705
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differences in solute removal by two high-flux membranes of nominally similar synthetic polymers.
    Ouseph R; Hutchison CA; Ward RA
    Nephrol Dial Transplant; 2008 May; 23(5):1704-12. PubMed ID: 18156455
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Choosing a dialyzer: What clinicians need to know.
    Haroon S; Davenport A
    Hemodial Int; 2018 Oct; 22(S2):S65-S74. PubMed ID: 30296005
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Review: understanding sorbent dialysis systems.
    Agar JW
    Nephrology (Carlton); 2010 Jun; 15(4):406-11. PubMed ID: 20609091
    [TBL] [Abstract][Full Text] [Related]  

  • 79. What are the potential solutions for the problems with current methods for quantifying hemodialysis?: "difficult to remove" uremic toxins.
    Vanholder R; Eloot S; Van Biesen W
    Semin Dial; 2008; 21(5):407-9. PubMed ID: 18945327
    [No Abstract]   [Full Text] [Related]  

  • 80. Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis.
    Churchwell MD; Pasko DA; Smoyer WE; Mueller BA
    Nephrol Dial Transplant; 2009 Jan; 24(1):231-8. PubMed ID: 18723569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.